Slow and steady wins the race: precision medicine for low risk endometrial cancer

Int J Gynecol Cancer. 2020 Jun;30(6):724-725. doi: 10.1136/ijgc-2020-001467. Epub 2020 May 5.

Authors

Katherine C Kurnit¹, Shannon Neville Westin²

Affiliations

¹ Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL, USA.
² Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA swestin@mdanderson.org.

PMID: 32376741
DOI: 10.1136/ijgc-2020-001467

No abstract available

Keywords: uterine cancer.

Publication types

Editorial
Comment

MeSH terms

Endometrial Neoplasms*
Female
Humans
Precision Medicine*